A peptide COA is useful when you can connect its results to the exact material you are buying. Start with the product, tested sample and lot, then review the methods, units and limits behind each result.
Editorial review: 12 November 2026. Prepared by Velnacor Research Desk for qualified research and B2B procurement teams.
1. Match the report to the material in your quotation
Before reading a purity percentage, compare the product name, chemical form, specification and supplier lot reference across the quotation, report and proposed label. Similar names are not enough. A blend, a single compound and a differently modified peptide require different documentation.
Record the laboratory sample identifier separately from the supplier’s batch number. If a field is missing, request a written explanation of how the sample relates to the material offered. Do not silently fill the gap with the product’s marketing name.
A report for a reference sample or a previous shipment can help you understand the supplier’s documentation. It does not, by itself, establish the results for a new lot or every vial in an order. Velnacor’s COA Library identifies its linked documents as tested reference-sample reports. Confirm the current lot and specification separately.
2. Verify the original report with the issuing laboratory
Use the laboratory’s own website or published contact channel to check a report when verification is available. Compare the original result with the copy you received, including the identifier, sample description, date, units and any notes.
For example, Janoshik’s verification page asks for a task number and unique key. Other laboratories may use a different process. A failed lookup needs clarification from the issuer; it should not be replaced by reassurance from a screenshot.
Keep two decisions separate: whether the report is authentic, and whether the tested sample is traceably connected to your order. A genuine laboratory report can still refer to a different sample. Save the original file and the supplier’s lot-matching explanation together.
3. Separate identity, purity and quantity
The test name matters as much as the number. This table is a reading aid, not a statement that every report includes every test.
| Identity | Ask which method supports the material’s identity. Mass-spectrometry results can contribute molecular-mass evidence; the required level of identification depends on the material and method. |
|---|---|
| Chromatographic purity | Read the method and reporting basis. A peak-area percentage describes the detected chromatographic profile under those conditions. It is not automatically a mass-fraction result. |
| Quantity or assay | Look for a separately reported result and units, such as mg per vial. Confirm what was measured and how the calculation relates to the tested sample. |
| Additional testing | Water, residual solvents, elemental impurities or microbiological measurements address separate questions. Do not infer them from an identity or purity result. |
| Acceptance criteria | Compare results with the written specification agreed for the order. A number without a defined requirement is not a complete purchasing decision. |
Analytical methods have different scopes. Agilent’s peptide analytical workflow compendium describes distinct methods for identity, impurities and other quality attributes. It is a technical reference, not evidence that Velnacor holds a certification or has performed those tests on a particular lot.
4. Do not calculate vial content from a purity headline
Illustrative purchasing example: a quotation states 10 mg per vial, while a report shows 99% chromatographic purity but no quantity result. You cannot conclude that the vial contains 9.9 mg of the target material. The nominal amount and the chromatographic percentage do not provide the missing measurement.
Ask whether quantity was tested, what the reported unit means and which sample was measured. A result in mg/mL, mg/vial and percentage by mass is not interchangeable without the appropriate information and calculation.
5. Check what was actually sampled
Ask who selected the sample, whether it was raw material or a finished vial, when it was collected and how it was identified during shipment to the laboratory. Agree a sampling plan appropriate to your procurement requirements with qualified quality personnel.
A tested raw-material sample and a tested finished vial answer different questions. One tested vial also does not demonstrate the contents of every vial in a shipment. If a supplier uses a retained sample, request its relationship to the proposed lot and any relevant packaging or handling records.
Independent testing can add evidence, but the scope must be agreed. Laboratory service menus distinguish core analysis from additional services. Review the selected tests and reporting limits rather than assuming that a third-party logo covers every quality attribute.
6. Keep an order-level document checklist
For each product and specification, keep a simple record with the following fields:
- Quotation or purchase-order reference and exact product description.
- Supplier lot reference and laboratory sample or report identifier.
- Original report, issue date and verification outcome.
- Tests performed, results, units and agreed acceptance criteria.
- Written explanation of the link between the tested sample and the offered material.
- Open questions, the person responsible for resolving them and the review date.
Mark an item as unresolved when a report is missing or the lot connection is unclear. A practical next step is to hold confirmation of that line item until the responsible team has reviewed the missing evidence. This checklist supports procurement review; it does not replace your organization’s quality procedures.
7. Ask a precise question before confirming supply
A useful document request is: “Please confirm the current specification and lot for this quotation, provide the available original reports, and explain how the tested sample relates to the material proposed for this order.”
Send your product selection, specification, box quantity and destination with the request. You can review the available COA reference reports first, then request an order-specific documentation review. The minimum order shown in the catalog is one box of ten vials; shipping is confirmed separately.
Primary references and scope
- Janoshik: report verification — the issuer’s report-authentication interface.
- Janoshik: overview of the testing process — selection of analyses, sample handling and final reports.
- Janoshik: additional analytical services — examples of separately scoped tests and result formats.
- Agilent: analytical workflows for peptide therapeutics — analytical-method background only.
Research-use scope. A COA does not establish approval, sterility, or suitability for human or veterinary use. This guide addresses document review for research procurement and provides no dosing, administration or treatment instructions.